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We have been using a differential cDNA cloning approach to isolate human retina-specific and retina-enriched genes [1]. A 1,314 bp cDNA was 
isolated by this approach, representing a highly retina-specific message ncoding a 388 amino acid protein showing 58%, 50%, and 49% homology 
to bovine fl-arrestin, and bovine and human retinal arrestin (S-antigen), respectively. Chromosomal mapping localized this new arrestin gene to 
the proximal ong arm of the X chromosome, hence it was named X-arrestin. In situ hybridization demonstrated itsexpression i  the inner and 
outer segments and the inner plexiform regions of the retina. 
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1. INTRODUCTION 
Isolation and characterization f retinal genes, such 
as rhodopsin [2], peripherin [3], cGMP-phospho- 
diesterase (the fl subunit of which is the gene involved 
in a mouse model of retinal degeneration, the rd mouse) 
[4], arrestin (S-antigen) [5], ~-transducin [6], phosducin 
[7], recoverin [1], cellular retinaldehyde binding protein 
[8], and interphotoreceptor retinol binding protein [9], 
have contributed greatly towards understanding retinal 
biology. A candidate gene approach using these genes 
(rhodopsin and peripherin) has led to the identification 
of the causative gene in some cases of autosomal domi- 
nant retinitis pigmentosa [10-12]. In an effort to further 
understand the biology of the human retina in normal 
and diseased states, we have been using a differential 
cDNA cloning approach to isolate human retina-spe- 
cific and retina-enriched genes. This approach as al- 
ready resulted in the isolation of the human recoverin 
cDNA and gene [1]. We report here the isolation of 
another etina-specific gene, arrestin, by this approach. 
Retinal arrestin or S-antigen is a phototransduction 
protein found abundantly in the photoreceptors and 
thought o play a role in inactivation of light-activated 
rhodopsin [13,14]. S-Antigen is thought o quench the 
phototransduction cascade by binding to light-acti- 
vated, phosphorylated rhodopsin, thereby blocking its 
interaction with transducin. S-Antigen is welt conserved 
among species, and homologues have been isolated 
from cow, rat, human, and fruit fly [5,15-18]. Another 
type of arrestin, fl-arrestin, has also been isolated and 
shown to specifically inactivate the fl-adrenergic reeep- 
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tor [19 21]. Thus, different ypes of arrestin mediate 
desensitization f specific receptors in signal transduc- 
tions. The human arrestin we isolated is retina-specific 
in expression, homologous to fl-arrestin and S-antigen 
but distinct from them, mapped to the X chromosome 
(hence named X-arrestin), and localized to the outer 
and inner segments and inner plexiform region of the 
retina. 
2. MATERIALS AND METHODS 
2.1. Preparation of retina-enriched cDNA library 
A retina-enriched cDNA library was prepared as previously de- 
scribed [1]. Briefly, mRNA was isolated from the human retina, con- 
verted to double-stranded cDNA, subtracted with biotinylated fibro- 
blast cDNA several times using streptavidin in combination with 
polymerase chain reaction (PCR) amplification, and cloned into 
pBluescript (Stratagene, La Jolla, CA). Approximately 300 recombi- 
nant clones were isolated. The present retina-specific clone was iso- 
lated in the initial analysis of 30 clones. 
2.2. Northern blot analysis 
Total human retinal, retinal pigment epithelium, and fibroblast 
RNA were isolated from tissue or cells using guanidine thiocyanate 
[22]. Human brain, liver, and lung RNA were obtained from Clone- 
tech (Palo Alto, CA). The RNA was electrophoresed in denaturing 
agarose gels [23], transferred onto nylon membranes by the Southern 
blotting method [24], and hybridized with a 32p-labeled DNA probe. 
The hybridized blots were washed and autoradiographed as described 
before [25]. 
2.3. DNA sequencing 
DNA was sequenced by the dideoxy chain termination method 
using the Sequenase DNA sequencing kit [26] (United States Biochem- 
ical, Cleveland, OH). Sequences were analyzed by the IntelliGenetics 
(Mountain View, CA) and Genetic Computer Group (Madison, WI) 
software packages. 
2.4. Sublocalization f X-arrestin on the X chromosome 
High-molecular weight genomic DNA from rodent-human somatic 
hybrids containing different segments of the human X chromosome 
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(gift of Dr. T. Mohandas [27]) was digested with EcoRI, electrophore- 
sed in 0.8% agarose gels, transferred onto nylon filters by the Southern 
method [24], and hybridized to 32P-labeled cDNA probes. The hybrid- 
ized filters were washed and autoradiographed as described [25]. The 
accuracy of the DNA panel was checked by the hybridization of a 
known X chromosome marker, TIMP (ATCC, Rockville, MD, [28]), 
to the blot which showed the correct localization to the Xp region 







2.5. In situ hybridization 
The whole eye (rat, human) was cut open, fixed in 4% paraformal- 
dehyde, and immersed in 30% sucrose solution overnight. The tissue 
was frozen, sectioned, fixed again in 4% paraformaldehyde, treated 
with or without proteinase K, rinsed, and prehybridized in a mixture 
containing 50% formamide, 10% dextran sulfate, 1 x Denhardt’s mix- 
ture, and blocking tRNA. The probe was the sense (control) and 
antisense riboprobes prepared from a truncated X-arrestin Bluescript 
cDNA clone (1,130-1,314 bp at the 3’ end) by transcription from 
either the T3 or T7 promoter with incorporation of [YS]ribonucleo- 
tides (Stratagene). Hybridization was carried out overnight at 50°C 
and the sample was treated with RNase A. The slides were washed 





3. RESULTS AND DISCUSSION 
B 
A human retina-enriched cDNA library was prepared 
by repeated subtraction of a retina cDNA population 
with a biotinylated fibroblast cDNA population fol- 
lowed by amplification of the remaining clones by 
polymerase chain reaction [l]. Approximately 300 ret- 
ina-specific or -enriched cDNA clones were obtained, 
and thirty were initially analyzed. Enrichment for reti- 
nal genes was confirmed by the identification of rho- 
dopsin, a-transducin, cGMP-phosphodiesterase y, and 
recoverin among the first ten cDNAs analyzed [33]. 
A cDNA clone was identified which showed a highly 
retina-specific pattern of expression on Northern analy- 
sis of RNA from human liver, lung, brain, fibroblast, 
retinal pigment epithelium, and neuroretina (Fig. 1). A 
single specie of 1.35 kb was observed. Sequence analysis 
of the clone revealed a nearly full-length 1,314 bp 
cDNA with a polyadenylation signal at position 1,269 
and a poly(A) sequence at the 3’ end (Fig. 2). An open 
reading frame began with an ATG codon at position 52, 
with a good consensus sequence for translation initia- 
tion codon [34], and ended with a termination codon at 
position 1,216, resulting in a protein of 388 amino acid 
residues and a calculated molecular mass of 42,864. 
Fig. 1. Northern blot analysis of human mRNA with the retinal cDNA 
probe. RNA from different human tissues are present in lanes l-7: 1, 
lung; 2, liver; 3, brain; 4, retinal pigment epithelium; 5, neuroretina; 
6 and 7, skin fibroblast. (A) Hybridized with “P-labeled cDNA clone; 
arrow points to the transcript of approximately 1.35 kb seen only in 
the retina. (B) Hybridized with the human b-actin probe to check on 
the quantity and quality of RNA present in each lane. Positions of the 
28 S and 18 S ribosomal RNA and RNA standards are shown. 
Comparison of the protein sequence with those in the 
Protein Information Resource sequence databank by 
the FastDB program (Intelligenetics Inc.) showed it to 
be most similar to arrestin, a protein involved in recep- 
tor-mediated homologous desensitization of retinal 
photoreceptors [13,14], and ,&adrenergic receptors [ 191. 
The highest homology was with bovine /?-arrestin [19] 
at 58%, followed by rat p-arrestin 1 [20] at 57%, human 
thyroid arrestin (putative human B-arrestin) [21], and 
rat /I-arrestin 2 [20] at 52%, bovine retinal and rat pineal 
arrestin (S-antigen) [15,16] at 50%, human retinal ar- 
restin (S-antigen) [5] at 49%, and Drosophila miranda 
arrestin [35] at 37%. Despite the highest homology with 
the j?-arrestins, the new arrestin (X-arrestin) seemed to 
be distinct from the /?-arrestins in that the homology 
between X-arrestin and the /Y-arrestins (52-58%) was 
significantly lower than the homology among the 
human, rat, and bovine homologues of p-arrestin (74 
99%) [20,21]. X-Arrestin was also clearly distinct from 
the original retinal arrestins (S-antigen) since it was only 
49-50% homologous to them, while the homology 
among the retinal arrestins is over 80% [5,15,16]. Thus, 
the bovine /3-arrestin, human thyroid arrestin (putative 
j?), bovine and human retinal arrestin (S-antigen), and 
X-arrestin sequences were multiply aligned by the GEN- 
ALIGN program (Intelligenetics Inc.) in order to 
closely examine the nature of the homologies (Fig. 3). 
The homology among these arrestins existed 
throughout the sequence except for the carboxy-termi- 
nals. Divergence of the carboxy-terminal sequence in 
the arrestins has been noted previously [19,20]. Forty to 
sixty residues at the carboxy-termini of arrestins showed 
divergence, with the /I-arrestins and the retinal arrestins 
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GAACTTCATCTCTCTCCCCAGAAAAGG~TCAA~ATCAACTATATAGCCAACATGT~CAAGGTGTTTAAGAAGACCAGCTCCAATGGGAAG 
1 . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + 90  
1 MetSerLysVa lPheLysLysThrSerSerAsnGlyLys  13  
CTCTCCATCTACCTGGGGAAACGGGACTTCGTGGACCATGTGGACACGGTGGAACCCATTGACGGTGTTGTCCTGGTTGATcCTGAGTAC 
91  . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  ÷ 180  
14  Leu~er I~eTyrLeuG~yLysArgAspPheVa~A~pHisVa~As~ThrVa~G~uPr~I~eAspG~yVa~Va~LeuVa~AspPr~GluTyr  43  
TTAAAATGTCGAAAGTTGTTTGTCATGTTGACATGTGCCTTTCGCTATGGCCGTGATGACTTGGAAGTGATTGGT•TGAcGTTCCGAAAA 
181  . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + 270  
44  LeuLy•CysArgLysLeuPheVa•MetLeuThrCysA•a•heArgTyrG•yArgAspAspLeuG•uVa•I•eG•yLeuThrPheArgLy• 73 
GATCTGTATGTGCAGACCCTGCAAGTGGTCCCAGCTGAAT•CAGCAGCCCTCAGGGCGcCCTCACAGTCCTACAGGAG•GA•TACTG•A• 
271 . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  ÷ . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + 360  
74  AspLeuTyrValG•nThrLeuG•nVa•Va•Pr•A•aG•uSer•er•erPr•G•nG•yA•aLeuThrVa•LeuG•nGluArgLeuLeuHis 103 
AAGCTAGGGGACAATGCCTACCCCTTTACCCTGCAGATGGTGACCAACCTGCCCTGTT•TGTGAcACTGCAGCCAGGTCCTGAAGATGCA 
361 . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + 450  
104  LysLeuG••AspAsnA•aT•rPr•PheThrLeuG•nMetVa•ThrA•nLeuPr•CysSerVa•ThrLeuG•nPr•GlyPr•G luAspA la  133  
GGAAAG•C•TGTGGGATTGACTTTGAAGTGAAGAGTTTCTGTGCTGAAAAC•CAGAGGAGACAGTCTCCAAGAGAGACTATGTGCGGCTG 
451 . . . . . . . . .  + . . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  ÷ . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + 540  
134  G•yLysPr•CysG•yI•eAspPheG•uVa•LysSerpheCysA•aG•uAsnpr•G•uG•uThrVa•SerLysArgAspTyrVa•ArgLeu 163 
GTTGTCCGGAAAGTACAATTTGCACCACCGGAGGCAGGCCCTGGCCCCTCAGC•CAGACCATCCGCCGCTTCCTTCTGT•AGCTCAGCCC 
541 . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + 630  
164  Va•Va•ArgLysVa•G•nPh•A•aPr•Pr•G•uA laG•yPr•G•yPr•SerA•aG•nThr I leArgArgPheLeuLeuSerA•aG•nPr•  193  
CTACAACTCCAGGCCTGGATGGACAGGGAGGTTCACTACCACGGAGAACCCATCTCTGTCAATGTTTCTATCAACAACTGCACCAACAAG 
631 . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + 720  
194  LeuG•nLeuG•nA•aTrpMetA•pArgG•uVa lH isTyrH isG•yG•uPr• I•e•erVa•AsnVa lSer I•eAsnAsnCysThrAsnLys  223  
GTCATCAAAAAAATCAAGATTTCAGTTGACCAGATCACAGATGTTGTCCTGTATTCACTAGACAAGTACACCAAGACTGTGTTCATTCAG 
721 . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + 810  
224  Va• I•eLysLys••eLys I leSerVa•AspG•n I•eThrAs•Va•Va lLeuTyr•erLeuAspLysTyrThrLysThrVa••he I•eG•n 253  
GAATTCACGGAGACTGTAGCTGCTAATTCCAGCTTCTCCCAGAGCTTTGCAGTAACCCCAATCCTGGCTGCCAGCTGCCAGAAACGGGGC 
811 . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + 900  
254  G•uPheThrG•uThrVa•A•aA•aAsnser•erPheSerG•nSerPheA•aVa•Thr•r• I•eLeuA•aA•aSerCysG••LysArgG•y  283  
CTGGCACTGGATGGcAAACTTAAGCAT•AAGATACCAACCT•CCCTCTAGCACAATTATTAGACCGG•AATGGACAAAGAGCTGCTGGGG 
901 . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + 990  
284  LeuA•aLeuAspG•yLysLeuLysHisG•uA•pThrAsnLeuA•aSerSerThrI•eI•eArgPr•GlyMetAspLysG•uLeuLeuG•y 313 
AT•CTGGTGTCCTACAAAGTCAGAGTCAACCTGATGGTGTCCTGTGGTGG•ATCCTAGGAGACCTGACAGCCAGCGATGTTGGTGTGGAG 
991 . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + I080  
314  I~eLeuVa~SerTyrLysVa~ArgVa~AsnLeuMetVa~S~rCysG~yG~yI~eLeuG~yAspLeuThrA~aSerAspVa~G~yVa~G~u 343 
CTACCCTTGGTCCTGATCCATCCGAAGC•ATCTCATGAGGCCGCTAGCTCTGAGGACATAGTCATCGAGGAGTTTACGCGGAAAG•CGAG 
1081 . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  ÷ . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + 1170 
344  LeuProLeuValLeuIleHisProLy sPrOSerHisGluAlaAlaserSerGluAspIleValIleGluGluPheThrArgLysGlyGlu 373 
GAGGAGAGCCAGAAGGCTGTGGAGGCTGAGGGAGATGAGGGGAGCTGAGCACCTCGCTCTGGTGCCCGTCTGTGTG•GAGCCCCCACTGT 
1171 . . . . . . . . .  + . . . . . . . . .  ÷ . . . . . . . . .  * . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + 1260 
374  GluGluSerGlnLysAlaValGluAlaGluGlyAspGluGlySerEnd 388 
AACACTCTAATAAATCAGTTTGTTCAGATGTGAAAAAAAAAAAAAAAAAAAAAA 
1261 . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . . . . . . .  + . . . .  1314  
Fig. 2. Nucleotide and derived protein sequence of the retinal cDNA. The putative initiation methionine and termination codons are underlined. 
The translation yields a 388 amino acid protein. The polyadenylation signal at nucleotide 1,269 is ove~ined. 
(S-antigen) losing homology at around residue 330, X- 
arrestin losing homology at around residue 353, and the 
two fl-arrestins (bovine and human thyroid) and the two 
retinal arrestins (bovine and human S-antigen) retaining 
homology relatively well to the carboxy termini. Thus, 
the uniqueness of X-arrestin's carboxy-terminal region 
seemed to support its distinctness from the other ar- 
restins. 
Partial sequence similarities between arrestin and 
transducin c~, a guanine nucleotide-binding, signal-cou- 
pling protein [36-38], have been demonstrated, and they 
are designated in Fig. 3. These include three phosphoryl 
binding sites and the pertussis toxin ADP-ribosylation 
site described in retinal arrestin (S-antigen) [5,39], and 
five regions similar to transducin c~ described in bovine 
fl-arrestin [19]. These sequence similarities support the 
hypothesis that arrestin mimics transducin and interacts 
directly with the sensory receptor to result in homolo- 
gous desensitization [5,13,14]. Binding of retinal ar- 
restin to phosphorylated photoreceptor hodopsin and 
fl-arrestin to phosphorylated fl-adrenergic receptor with 
subsequent desensitization have been shown [14,19]. X- 
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D--G 1. 
XARRESTIN I mskVFKKt S sNGKLs IY LGKRDFVDHv Dt VEPi DGWLVDPEY LKcRk I fVmLTCAFRYGRdDLeViGLTFRKDLyvqt  
ll[i I IIII l l l l l l II l l t III l i lt lt l l l l l l  I I l l l l l III l I I I  IIIIIIII 
BOVARRB 1 MG d kGTRVFKK a SP NGKLTVY LGKRDFVDHi D IVEPVDGWLVDPEYLKeRrVyVTLTCAFRYGREDLDVLGLTFRKDL FvA 
11 I l l l l t l  11t I I i t1111111111 1 I I I I i t t11 I I  111 I [ I t l l l l l l l l l l [ l l l l l l  I l t l t  I I 
HUMARRESTM l MGeKP GTRVFKK sSP NcKLTVYLGKRDFVDHLDkVdPVDGWLVDPdY LKdRkV fVTLTCAFRYGREDLDVLGLSFRKDL FiA 
I I  111 l t I11111 I l l  l I [ l l l l l l l l  I I I I I I I I I I I  I I  I I  I I I I I  I1 
BOVANTS 1 mKa nKP aP NHV I FKKI SRDKSVT IY LGKRDY I DHLe rVePVDGWLVDPeLVKGKrVYVsLTCAFRYGQEDi  DVmGLSFRRDL YFS 
I I I l t l l l l l l l l l l l l l l l l l  I I I I l l  I I I I I I I I I I I  I I I I I  I I I  I I In l l l l l l l  I I  I I  I I I I i  I I I  
HUMRETSA i maasgKtsKse•NHVIFKK••RDK••T•YLGnRDY•DHvsqVqP•DGwLVDPdLVKGKkVYVtLTCAFRYGQEDvDV•GLtFRRDL YFS
consensus maa s- -g-kp-p- - -vFKKiS-n-k  i t iYLGkRD fvDH-d-VePvDGWLVDPey lKgrkvyVt  LTCAFRYGreDIdV-GLt  FRkDLy- f- 
2 g/i~xxx~ 
XARRESTIN . 80 IqvvpaessspqgaLTvLQERLIhKLGdnAYPFTIqmvtNLPCSVTLQPGPEDaGKpCGiDfEVKsF CAENpEE tvsKRdyVRLVvRK 
I t  t t l l t  t l l  t l t l t  t t l l t1 I i t l t l t l  I I  I I  I I I I  I I I I I  I1 1t I l t l  t l  
BOVARRB 83 nvQsFPPaPedkkPLTRLQERL ikKLGeHAYPFTFe IPpNLPCSVTLQPGPEDTGKACGVDyEVKAF CAENLEE K iHKRNSVRLVIRK 
I I t l  I I I t l i  t l  1 t l  I1 I I  I I I  I l t l t l t l l l l l l l l l l l l t l l  I I I  I1 I t i  I I I I I I1111111 
HUMARRESTM 84 tyQaFPPVPnpprPpTRLQdRLI rKLGqHAhFFfFT IPqNLPCSVTLQPGPEDTGKACGVDFEI rAF  CAksLEE KsHKRNSVRLVIRK 
1 I t t l  I i t i  I I t l  11 t I I t l i t  I11 t I I I  I I I1111 11 I f  I I I I i t  I I1  
BOVANTS 87 qVQVFPPV GAsgatTRLQE•L iKKLGaNTYPFvLTFPDYLPC•VMLQ•A•QDvGK$•GVDFEIKAFAThSTDvEEDKIPKKSSVRLL•RK 
11I I I I  / I  I I I I I I  1111 I t l i i  I l l t l l l l l l l l l l t l l l l  t t l t l i i i i  I I111  I I I  1111111t1 I t l  t l l  
HUMRETSA 91 rVQVyPPV GAastpTkLQE$L•KKLGsNTY•F•LTF•DYLP••VMLQ•APQDsGKSCGVDFE•KAFATdSTDaEEDK•PK•SSVRyL•Rs  
consensus -vqvfppvpg--g--TrLQerL•kKLG-nayPFt•t-pdnLPCSVtLQ•gPeDtG•-CGvDfEVkaFatca--•EEdki-•r-sVR•viRk 
XARRESTIN 168 •QfAPpeaGPgPsAqT iRrF••SaqPLqLqAwmDrEvhYHGEPI•VNVs inNcTNKv iKK IK IsVdQ•tDvVLys•dkYtktVf iqEf teT  
I [  11 11 I 1 I I { I I I  I { { I {{[ l l l l l l l  I I [1  { l{ l l{ I  I I I { { I { 
BOVARRB 171 VQyA•ErPG•Q•tAETT•qF iMS•k•L••EAsLDKEiYYHGE•ISVNV•VTNNTN•TVKK•KI$••QYAD•CLFnTAQYKCPVAmeEaDDT 
I I  I l l  I l l l l  {111 I I I I  I l J l l l l l l l  I I I111  I l l l { l l l  I l l l l l l  I I l l l l l l l l {  I I l l l l l l l  I I I  
HUMARRESTM 172 VQfA•Ek•G•••sAETTphF•M•DrsLHLEA•LDKE•YYHGE•••VNVHVTN•stKTVKKIKVSV•QYADICLFSTAQYKCP•Aq•EqDDq 
I I I  I111 I I  I I I I  I I I I  I I  I l l l l l  I I I l l  I l l l l l l {  I I I I { I I  I 
BOVANTS 177 iQHAPrdMGPQPRAEAsWQFFM•DKPLrLAV•LsKE IYYHGEP IPVTVaVTNsTEKTVKKIK••VEQVtNwLYSSDYY iKtVAaEEAQEK 
I l J l  I [ l l l } t l l  I I l l l l l l { I  f l l l l  111 I I I I I l l l l  I I I  t l#11 l l l l  I l l {  { l l{ l l l{ l l  I I I  I l l l l l  
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Fig. 3. Alignment of multiple arrestin sequences. The protein sequences of the new X-arrestin (XARRESTIN), bovine fl-arrestin (BOVARRB), 
human thyroid arrestin (HUMARRESTM), bovine retinal arrestin (BOVANTS, S-antigen), and human retinal arrestin (HUMRETSA, S-antigen) 
were multiply aligned by the GENALIGN computer program (IntelliGenetics, Inc.). D--G and G/AXXXGK designate hree regions howing 
homology to GTP phosphoryl binding sites, and the shadowed residues in the BOVANTS and HUMRETSA sequences are homologous to the 
pertussis toxin ADP-ribosylation site [5,39]. The regions designated 1-5 have been shown to be similar to transducin ~ in bovine fl-arrestin [19]. 
Arrestin contains the three phosphoryl binding sites and 
regions 1 and 3 of the transducin c~-like sequences. 
These sequences are common to all of the arrestins 
being compared, whereas regions 2 and 5 are present 
only in bovine fl-arrestin and region 4 is common to 
bovine fl-arrestin and the putative human homologue, 
thyroid arrestin. Notably, the ADP-ribosylation site is 
not present in X-arrestin or the bovine and human (thy- 
roid) fl-arrestins. 
Chromosomal mapping of the X-arrestin gene by hy- 
bridization to panels of DNA from somatic ell hybrids 
containing specific human chromosomes (Oncor Inc., 
Gaithersburg, MD) (data not shown) and specific parts 
of the human X chromosome (Fig. 4) [27] localized the 
gene to Xcen-Xq21. Thus, X-arrestin joins the ranks of 
other retinal genes that have been localized to X, includ- 
ing the red and green opsins, and the genes for 
choroideremia and Norrie disease [2,40-42]. Interest- 
ingly, a Drosophila arrestin in D. miranda, to which 
X-arrestin shows the highest homology (37%) among fly 
arrestins, has also been mapped to X [35]. This arrestin 
is a homologue of that described by LeVine et al. (Arr2) 
[43] and Yamada et al. [17], and is distinct from Arrl,  
a homologue of S-antigen [43]. An interesting functional 
study of Arr2 has been published recently [44], and its 
relevance to X-arrestin will be discussed later. 
In situ hybridization analysis of X-arrestin using the 
rat and human retina demonstrated expression of this 
gene in the inner and outer segment and inner plexiform 
regions (Fig. 5). In view of the close homology among 
all the arrestins, the analysis was performed with a par- 
tial probe from the 3' end (1,130-1,314 bp) of the cDNA 
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representing the unique part of the X-arrestin sequence. 
A similar pattern of reaction in the photoreceptor cells, 
inner plexiform layer, and biopolar cells has been 
shown in a newt with antibodies against S- antigen [45]. 
The authors suggested that the reaction in the inner 
plexiform and bipolar cells may be due to arrestin re- 
lated to fl-adrenergic or similar chemical signal recep- 
tors. 
The presence of up to four different arrestins has been 
reported [46]. The precise identity' and function of X- 
arrestin eeds to be determined. Which receptor signal 
transduction does it regulate? Its distinctness from S- 
antigen and fl-adrenergic arrestin appears to be clear on 
the basis of the sequence differences and the uniqueness 
of the carboxy terminal region. It does not even appear 
to be a homologue of the third type of arrestin, repre- 
sented by the rat fl-arrestin 2 [20] since its homology to 
fl-arrestin 2 is 52%, similar to fl-arrestin 1 at 57%. De- 
spite its slightly higher homology to fl-arrestin, its ex- 
pression pattern (retina-specific) is more like that of 
S-antigen than that offl-arrestin, which is expressed in
multiple tissues [19]. Some of the in situ hybridization 
observed in the retinal inner and outer segments may 
represent cross-hybridization with S-antigen message 
(despite the use of a unique X-arrestin probe), but much 
of it most likely represents X-arrestin expression. 
S-Antigen has been postulated to mimic transducin 
and interact directly with photoactivated rhodopsin 
[5,13,14]. In this regard, the carboxy-terminal region 
including the ADP-ribosylation site has been consid- 
ered to be important [47,48]. The dissimilarity of the 
carboxy-termini, including the lack of the ADP-ribosyl- 
ation site in X-arrestin compared to S-antigen, appears 
to argue against identical functions for both, i.e. desen- 
sitization of rhodopsin signal transduction. Considering 
the sequence conservation between rhodopsin and color 
opsins [2], the involvement of X-arrestin in cone 
transduction also appears unlikely on the same 
grounds. The abundant pattern of in situ hybridization 
in the inner and outer segments also d es not appear to 
support he presence of X-arrestin only in the cones. A 
recent report of Drosophila rrestin 2, however, is inter- 
esting in that, in addition to arrestin 1, which has been 
considered to be the homologue of S-antigen [17,18], it 
was also shown to be involved in the inactivation f 
rhodopsin [44]. The distribution of arrestin 2 in the fly 
retina was identical to that of arrestin 1, somewhat 
similar to the localization of X-arrestin to the inner and 
outer segments where S-antigen is present. Arrestin 2 is 
the homologue of D. miranda arrestin (98% homology), 
which showed the highest homology to X-arrestin 
among the fly arrestins and which also mapped to the 
X chromosomes [35]. Despite the species difference, the 
human X-arrestin may be functionally similar to the 
Drosophila rrestin 2, and may also be involved in inac- 
tivation of rhodopsin. 
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Fig. 4. Sublocalization of X-arrestin on the X chromosome. The hy- 
bridization of the X-arrestin probe to EcoRI-digested genomic DNA 
from rodent-human somatic hybrids containing different segments of
the human X chromosome (gift of Dr. T. Mohandas) [27] is shown. 
The X segment contained ineach hybrid is schematically shown at the 
top. The arrowheads point to the X-arrestin gene bands visible in some 
of the hybrid DNA and normal human genomic DNA (lane 6). The 
DNA size markers are HindlII-digested 2. DNA. 
undefined retina-specific signal transduction. In this re- 
spect, its expression i  the inner plexiform region by in 
situ hybridization is especially interesting, fl-Adrenergic 
transduction might be a possibility in the inner plex- 
iform except we have shown that X-arrestin is distinct 
from fl-arrestin. Cross-hybridization with fl-arrestin 
message is a possibility, but use of the unique probe 
should have minimized it. The inner plexiform is where 
the bipolar, amacrine, and ganglion cells synapse, a site 
presumably of a variety of chemical signal transduc- 
tions. X-Arrestin may be involved in one of these synap- 
tic signal transductions that is highly retina-specific. 
Recently, new s-G-proteins have been isolated that 
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Fig. 5. In situ hybridization of X-arrestin in the rat and human retina. The results of liquid emulsion autoradiography of t e retina sections after 
hybridization with the X-arrestin sense or antisense riboprobes are shown. (A) Ratretina; (B) human retina, as, antisense; s, sense; GC, ganglion 
cell layer; I.P, inner plexiform; IN, inner nuclear layer; OP, outer plexiform; ON, outer nuclear layer; IS, inner segment; OS, outer segment; PE, 
pigment epithelium. 
lack the carboxyl ADP-r ibosylation site and are insensi- 
tive to pertussis toxin [49,50]. These G-proteins are sug- 
gested to play a role in signal transductions involving 
receptor-mediated activation of  phospholipase C, as is 
the case in invertebrate phototransduction [50]. Phos- 
pholipase C has been demonstrated in bovine rod outer 
segments (ROS) [51 ], and its activation by light has been 
shown in several species [51-53]. In fact, activation of  
bovine ROS phospholipase C by arrestin (assumed to 
be S-antigen) was recently reported [54]. In view of the 
absence of pertussis toxin ADP-ribosylation site in X- 
arrestin, it is interesting to speculate that X-arrestin may 
be involved in such a system. I f  true, X-arrestin may 
indeed be very similar functionally to the Drosophila 
arrestin 2 [44]. In vitro expression of  the gene product 
and biochemical testing of  such functions as quenching 
of  opsin-mediated and fl-adrenergic receptor-mediated 
transduction, and activation of  phospholipase C should 
help in identifying X-arrestin. 
Note added in proof  
Recent personal communicat ion has indicated that 
Dr. C. Craft and colleagues may have isolated a similar 
arrestin. 
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